After Australia, 5 more countries recognise India’s Covaxin

New Delhi:  After Australia recognised Bharat Biotech’s Covaxin for allowing entry of travellers who had received the vaccine, five more countries on Monday recognised India’s vaccine certificate. These five countries recognised both Covaxin and Covishield.
The Ministry of External Affairs (MEA) said that five more countries have recognised India’s vaccination certificate, including Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia.
In a tweet in the evening, MEA spokesperson Arindam Bagchi said, “Mutual recognition of Covid-19 vaccination certificates continues! Five more recognitions for India’s vaccination certificate, including from Estonia, Kyrgyzstan, State of Palestine, Mauritius and Mongolia.” Earlier, in the day Australia recognised Bharat Biotech’s Covaxin along with Covishield for allowing entry of travellers who had received the vaccine. The Therapeutic Goods Administration (TGA), the Australian drug regulator, announced that it has recognised two more Covid-19 vaccines not registered in Australia but used widely internationally, which includes Bharat Biotech’s Covaxin and BBIBP-CorV (manufactured by Sinopharm, China).
The TGA further stated that with recognition of Covaxin, and BBIBP-CorV, along with the previously announced recognition of Coronavac (manufactured by Sinovac, China) and Covishield (manufactured by AstraZeneca), means many citizens of India and China as well as other countries in the region where these vaccines have been widely deployed will now be considered fully vaccinated on entry to Australia.
The TGA stated that this will have significant impact for the return of international students, and travel of skilled and unskilled workers to Australia.